Lipigon Pharmaceuticals AB (fra:9RP) Share Price

Company Profile

Business description
Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.
Contact
Tvistevagen 48 C
Umea90736
SWE
T: +46 705781768
E: [email protected]
https://www.lipigon.se
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
7

Recommended

Investors cheered an increased dividend but still heavily dependent on iron ore.

Jon Mills, CFA | 18 February 2026

Our view of the shares after investors cheer results.

Jon Mills, CFA | 17 February 2026

We maintain our fair value as talks continue with Paramount,

Matthew Dolgin, CFA | 17 February 2026

Index	Last price	Change	% Change
All Ordinaries	9,238.70	21.50	0.23%
CAC 40	8,361.46	44.96	0.54%
DAX 40	24,998.40	197.49	0.80%
Dow JONES (US)	49,533.19	32.26	0.07%
FTSE 100	10,545.22	71.53	0.68%
HKSE	26,705.94	138.82	0.52%
NASDAQ	22,578.38	31.71	0.14%
Nikkei 225	57,143.84	577.35	1.02%
NZX 50 Index	13,247.02	215.40	1.65%
S&P 500	6,843.22	7.05	0.10%
S&P/ASX 200	9,007.00	12.80	0.14%
SSE Composite Index	4,082.07	51.95	-1.26%